The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
PILGRIM: Phase III clinical trial in evaluating the role of hyperthermic intraperitoneal chemotherapy for locally advanced gastric cancer patients after radical gastrectomy with D2 lymphadenectomy(HIPEC-01).
 
Shu-zhong Cui
No Relationships to Disclose
 
Han Liang
No Relationships to Disclose
 
Yong Li
No Relationships to Disclose
 
Yanbing Zhou
No Relationships to Disclose
 
Kaixiong Tao
No Relationships to Disclose
 
Zhiwei Zhou
No Relationships to Disclose
 
Guoxin Li
No Relationships to Disclose
 
Peiyu Li
No Relationships to Disclose
 
Baojun Zhou
No Relationships to Disclose
 
Hongliang Yao
No Relationships to Disclose
 
Zheng Peng
No Relationships to Disclose
 
Bin Xiong
No Relationships to Disclose
 
Minghui Pang
No Relationships to Disclose
 
Shirong Cai
No Relationships to Disclose
 
Yong Li
No Relationships to Disclose
 
Jin Wan
No Relationships to Disclose
 
Bin Liang
No Relationships to Disclose
 
Ziying Lei
No Relationships to Disclose
 
Jiping Wang
Stock and Other Ownership Interests - GenomiCare
Honoraria - GenomiCare; GenomiCare
Consulting or Advisory Role - GenomiCare
Research Funding - GenomiCare
Travel, Accommodations, Expenses - GenomiCare